For example, in the 2022 American Diabetes Association (ADA) guidelines of standards of care in diabetes, the GLP-1 RAs benefits make them a preferred choice for treating T2DM in patients with additional complications or at risk for complications such as atherosclerotic cardiovascular disease, chronic kidney disease, and obesity [13]. Here, GCG is linked to type 2 diabetes mellitus.